SCHEMBL43099

SCHEMBL43099

CC(C)CC(O)C(C)CO

nearest known ligand 0.44

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 2/20 0.42
LMNA P02545 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.32
ANPEP P15144 1/20 0.31
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12938329 1.00 TSHR (0.44) TSHRTDP1LMNAL3MBTL1ALDH1A1
SCHEMBL10804648 0.83 TSHR (0.40) TSHRTDP1LMNAL3MBTL1ALDH1A1
SCHEMBL16074688 0.82 TDP1 (0.50) TSHRTDP1LMNAL3MBTL1ALDH1A1
SCHEMBL13839699 0.80 LMNA (0.42) TSHRTDP1LMNAL3MBTL1ALDH1A1
SCHEMBL2230287 0.80 TDP1 (0.40) TSHRTDP1LMNAL3MBTL1
SCHEMBL9740003 0.79 TSHR (0.47) TSHRTDP1LMNAL3MBTL1ALDH1A1
SCHEMBL12264068 0.78
SCHEMBL2386043 0.78
SCHEMBL1988036 0.78
SCHEMBL7882754 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170258703-A1 IONIC/IONOGENIC COMB COPOLYMER COMPOSITIONS AND PERSONAL CARE PRODUCTS CONTAINING THE SAME EVONIK DEGUSSA GMBH (DE) 2017-09-14 US claimed
US-20110046059-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-02-24 US claimed
WO-2011011675-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-01-27 WO claimed
CN-1110541-C Concentrated water-dispersible stable fiber softener compositions PROCTER & GAMBLE (US) 2003-06-04 CN claimed
CN-1098350-C Fabric softening compound/composition PROCTER & GAMBLE (US) 2003-01-08 CN claimed
CN-1244212-A Improved expression vectors PROCTER & GAMBLE (US) 2000-02-09 CN claimed
CN-1219953-A Fabric softening compound/composition PROCTER & GAMBLE (US) 1999-06-16 CN claimed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN claimed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN claimed
US-12528888-B2 Process for producing an aqueous polymer dispersion BASF SE (DE) 2026-01-20 US disclosed
WO-2025103901-A1 POLYMER DISPERSIONS FOR COATINGS BASF SE (DE) 2025-05-22 WO disclosed
CN-115461385-B Aqueous polymer dispersions 巴斯夫欧洲公司 2025-03-25 CN disclosed
EP-4389778-A1 AQUEOUS POLYMER DISPERSION FOR COATING COMPOSITIONS BASF SE (DE) 2024-06-26 EP disclosed
CN-114127135-B Process for preparing aqueous polymer dispersions 巴斯夫欧洲公司 2024-05-31 CN disclosed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO disclosed
WO-1996037525-A1 WATER-SOLUBLE COPOLYMERS CONTAINING POLYMERIZED-IN CROSS-LINKING AGENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1996-11-28 WO disclosed
WO-1996037598-A1 DYE TRANSFER INHIBITORS FOR DETERGENTS CONTAINING BLEACHING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1996-11-28 WO disclosed
WO-1996037524-A1 POLYMER AND SURFACTANT MIXTURES, PROCESS FOR THEIR PREPARATION AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1996-11-28 WO disclosed
WO-1996026229-A1 AGGLOMERATED FINE-PARTICLE CROSS-LINKED VINYL IMIDAZOLE COPOLYMERS, PROCESSES FOR PRODUCING THE SAID COPOLYMERS AND THE USE THEREOF BASF AKTIENGESELLSCHAFT (DE) 1996-08-29 WO disclosed
WO-1995035360-A1 COLOR MIGRATION INHIBITORS FOR WASHING AND CLEANING AGENTS BASF AKTIENGESELLSCHAFT (DE) 1995-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528888-B2 Process for producing an aqueous polymer dispersion CHRM1, CD14, CHRM2 TSHR 3841/4885TDP1 1216/4885LMNA 255/4885
US-20170258703-A1 IONIC/IONOGENIC COMB COPOLYMER COMPOSITIONS AND PERSONAL CARE PRODUCTS CONTAINING THE SAME C9, CUTA, ZYX TSHR 3364/4885TDP1 1939/4885LMNA 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.